Advertisement
Screener

Deciphera Pharmaceuticals, Inc. Net Income

Deciphera Pharmaceuticals, Inc. Net Income

Deciphera Pharmaceuticals, Inc. reported Net Income of -$45.08 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2024-05-10

  • Deciphera Pharmaceuticals, Inc. net income (loss) attributable to parent for the quarter ending 2024-03-31 was -$45.08M.
  • Deciphera Pharmaceuticals, Inc. net income (loss) attributable to parent for the quarter ending 2023-12-31 was -$47.15M.
  • Deciphera Pharmaceuticals, Inc. net income (loss) attributable to parent for the quarter ending 2023-09-30 was -$49.58M.
  • Deciphera Pharmaceuticals, Inc. net income (loss) attributable to parent for the quarter ending 2023-06-30 was -$48.56M.
  • Deciphera Pharmaceuticals, Inc. net income (loss) attributable to parent for fiscal 2022 was -$178.93M.
  • Deciphera Pharmaceuticals, Inc. net income (loss) attributable to parent for fiscal 2021 was -$299.96M.
  • Deciphera Pharmaceuticals, Inc. net income (loss) attributable to parent for fiscal 2020 was -$266.49M.
  • Deciphera Pharmaceuticals, Inc. net income (loss) attributable to parent for fiscal 2019 was -$192.26M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 12 month as first filed
2024-03-31-$45.08M
10-Q · filed 2024-05-10
-$92.23M
derived: sum of 2 quarters · filed 2024-05-10
-$141.81M
derived: sum of 3 quarters · filed 2024-05-10
-$190.37M
derived: sum of 4 quarters · filed 2024-05-10
2023-12-31-$47.15M
derived: 10-Q 12 month − 10-Q 9 month · filed 2024-05-10
-$96.73M
derived: sum of 2 quarters · filed 2024-05-10
-$145.29M
derived: sum of 3 quarters · filed 2024-05-10
-$194.90M
10-Q · filed 2024-05-10
-$194.94M
10-K · filed 2024-02-07
2023-09-30-$49.58M
10-Q · filed 2023-10-30
-$98.14M
derived: sum of 2 quarters · filed 2023-10-30
-$147.75M
10-Q · filed 2023-10-30
-$193.69M
derived: sum of 4 quarters · filed 2024-05-10
2023-06-30-$48.56M
10-Q · filed 2023-08-09
-$98.17M
10-Q · filed 2023-08-09
-$144.11M
derived: sum of 3 quarters · filed 2024-05-10
-$187.15M
derived: sum of 4 quarters · filed 2024-05-10
2023-03-31-$49.61M
10-Q · filed 2024-05-10
-$95.54M
derived: sum of 2 quarters · filed 2024-05-10
-$138.59M
derived: sum of 3 quarters · filed 2024-05-10
-$181.65M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31-$45.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07
-$88.98M
derived: sum of 2 quarters · filed 2024-02-07
-$132.04M
derived: sum of 3 quarters · filed 2024-02-07
-$178.93M
10-K · filed 2024-02-07
2022-09-30-$43.04M
10-Q · filed 2023-10-30
-$86.10M
derived: sum of 2 quarters · filed 2023-10-30
-$133.00M
10-Q · filed 2023-10-30
-$221.39M
derived: sum of 4 quarters · filed 2024-02-07
2022-06-30-$43.06M
10-Q · filed 2023-08-09
-$89.95M
10-Q · filed 2023-08-09
-$178.35M
derived: sum of 3 quarters · filed 2024-02-07
-$258.19M
derived: sum of 4 quarters · filed 2024-02-07
2022-03-31-$46.89M
10-Q · filed 2023-05-03
-$135.29M
derived: sum of 2 quarters · filed 2024-02-07
-$215.13M
derived: sum of 3 quarters · filed 2024-02-07
-$285.56M
derived: sum of 4 quarters · filed 2024-02-07
2021-12-31-$88.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07
-$168.23M
derived: sum of 2 quarters · filed 2024-02-07
-$238.67M
derived: sum of 3 quarters · filed 2024-02-07
-$299.96M
10-K · filed 2024-02-07
2021-09-30-$79.84M
10-Q · filed 2022-11-03
-$150.27M
derived: sum of 2 quarters · filed 2022-11-03
-$211.57M
10-Q · filed 2022-11-03
-$274.31M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30-$70.43M
10-Q · filed 2022-08-04
-$131.73M
10-Q · filed 2022-08-04
-$194.47M
derived: sum of 3 quarters · filed 2022-08-04
-$258.17M
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31-$61.30M
10-Q · filed 2022-05-04
-$124.04M
derived: sum of 2 quarters · filed 2022-05-04
-$187.74M
derived: sum of 3 quarters · filed 2022-05-04
-$254.98M
derived: sum of 4 quarters · filed 2022-05-04
2020-12-31-$62.74M
10-K · filed 2021-02-09
-$126.44M
derived: sum of 2 quarters · filed 2021-11-02
-$193.68M
derived: sum of 3 quarters · filed 2021-11-02
-$266.49M
10-K · filed 2023-02-07
2020-09-30-$63.70M
10-Q · filed 2021-11-02
-$130.94M
derived: sum of 2 quarters · filed 2021-11-02
-$203.75M
10-Q · filed 2021-11-02
-$270.96M
derived: sum of 4 quarters · filed 2021-11-02
2020-06-30-$67.24M
10-Q · filed 2021-08-03
-$140.05M
10-Q · filed 2021-08-03
-$207.26M
derived: sum of 3 quarters · filed 2021-08-03
-$263.46M
derived: sum of 4 quarters · filed 2021-08-03
2020-03-31-$72.81M
10-Q · filed 2021-05-04
-$140.02M
derived: sum of 2 quarters · filed 2021-05-04
-$196.22M
derived: sum of 3 quarters · filed 2021-05-04
-$217.68M
derived: sum of 4 quarters · filed 2021-05-04
2019-12-31-$67.22M
10-K · filed 2021-02-09
-$123.41M
derived: sum of 2 quarters · filed 2021-02-09
-$144.87M
derived: sum of 3 quarters · filed 2021-02-09
-$192.26M
10-K · filed 2022-02-08
2019-09-30-$56.20M
10-K · filed 2021-02-09
-$77.66M
derived: sum of 2 quarters · filed 2021-02-09
-$125.04M
10-Q · filed 2020-11-05
-$157.34M
derived: sum of 4 quarters · filed 2021-02-09
2019-06-30-$21.46M
10-K · filed 2021-02-09
-$68.84M
10-Q · filed 2020-08-04
-$101.14M
derived: sum of 3 quarters · filed 2021-02-09
-$125.58M
derived: sum of 4 quarters · filed 2021-02-09
2019-03-31-$47.38M
10-K · filed 2021-02-09
-$79.68M
derived: sum of 2 quarters · filed 2021-02-09
-$104.12M
derived: sum of 3 quarters · filed 2021-02-09
-$125.81M
derived: sum of 4 quarters · filed 2021-02-09
2018-12-31-$32.30M
10-K · filed 2020-03-09
-$56.73M
derived: sum of 2 quarters · filed 2020-03-09
-$78.42M
derived: sum of 3 quarters · filed 2020-03-09
-$99.85M
10-K · filed 2021-02-09
2018-09-30-$24.43M
10-K · filed 2020-03-09
-$46.13M
derived: sum of 2 quarters · filed 2020-03-09
-$67.56M
10-Q · filed 2019-11-04
-$87.47M
derived: sum of 4 quarters · filed 2020-03-09
2018-06-30-$21.69M
10-K · filed 2020-03-09
-$43.12M
10-Q · filed 2019-08-02
-$63.03M
derived: sum of 3 quarters · filed 2020-03-09
-$75.07M
derived: sum of 4 quarters · filed 2020-03-09
2018-03-31-$21.43M
10-K · filed 2020-03-09
-$41.34M
derived: sum of 2 quarters · filed 2020-03-09
-$53.38M
derived: sum of 3 quarters · filed 2020-03-09
-$64.01M
derived: sum of 4 quarters · filed 2020-03-09
2017-12-31-$19.91M
10-K · filed 2019-03-14
-$31.95M
derived: sum of 2 quarters · filed 2019-03-14
-$42.58M
derived: sum of 3 quarters · filed 2019-03-14
-$50.28M
10-K · filed 2020-03-09
2017-09-30-$12.04M
10-K · filed 2019-03-14
-$22.66M
derived: sum of 2 quarters · filed 2019-03-14
-$30.37M
10-Q · filed 2018-11-08
-$38.93M
derived: sum of 4 quarters · filed 2019-03-14
2017-06-30-$10.63M
10-K · filed 2019-03-14
-$18.33M
10-Q · filed 2018-08-07
-$26.89M
derived: sum of 3 quarters · filed 2019-03-14
-$32.99M
derived: sum of 4 quarters · filed 2019-03-14
2017-03-31-$7.71M
10-K · filed 2019-03-14
-$16.27M
derived: sum of 2 quarters · filed 2019-03-14
-$22.36M
derived: sum of 3 quarters · filed 2019-03-14
-$28.30M
derived: sum of 4 quarters · filed 2019-03-14
2016-12-31-$8.56M
10-K · filed 2018-03-28
-$14.66M
derived: sum of 2 quarters · filed 2018-03-28
-$20.59M
derived: sum of 3 quarters · filed 2018-03-28
-$25.94M
10-K · filed 2019-03-14
2016-09-30-$6.10M
10-K · filed 2018-03-28
-$12.03M
derived: sum of 2 quarters · filed 2018-03-28
-$17.38M
derived: sum of 3 quarters · filed 2018-03-28
2016-06-30-$5.93M
10-K · filed 2018-03-28
-$11.28M
derived: sum of 2 quarters · filed 2018-03-28
2016-03-31-$5.35M
10-K · filed 2018-03-28
2015-12-31-$19.82M
10-K · filed 2018-03-28